HOME >> MEDICINE >> NEWS
Cancer researcher Susan Horwitz wins Alpert prize for Taxol work

BOSTON-Susan Band Horwitz, Ph.D., the Falkenstein Professor of Cancer Research and Co-Chair of the Department of Molecular Pharmacology at the Albert Einstein College of Medicine, will today be awarded the 17th annual Warren Alpert Foundation Prize. The foundation recognizes Dr. Horwitz, a molecular pharmacologist, for her seminal contributions to the understanding of how the antitumor agent Taxol inhibits the growth of cancer cells. Her research helped pave the way for studies leading to approval of the plant compound for the treatment of ovarian, breast and lung cancers. The foundation will award Dr. Horwitz a $150,000 prize.

"One thing that Mr. Alpert stipulated when he developed this prize was that it should go to someone who had already made major contributions to helping patients. The impact of Susan's work has been quite extraordinary in the cancer field," said Professor Dominick Purpura, MD, Dean of Albert Einstein College of Medicine, who nominated Dr. Horwitz for the prize. In fact, earlier this year, shortly after Dr. Horwitz was selected as winner of the prize, she was acknowledged by her peers for her contributions to cancer research when she was elected to the National Academy of Sciences.

In the US, Taxol was first approved by the Food and Drug Administration (FDA) for the treatment of refractory ovarian cancer in 1992. Approval for metastatic breast cancer followed in 1994, and more recently for non-small cell lung cancer in 1999. "Taxol has become one of the most valuable cytotoxic chemotherapeutic agents we have in clinical oncology. It has proven effective in ovarian, breast, lung, and head and neck cancer and it has contributed immensely to the quality of life of cancer patients," said Larry Shulman, associate professor of medicine at the Dana-Farber Cancer Institute, Boston. The drug has been used in well over a million patients worldwide.

In 1977, Dr. Horwitz was approached by the National Cancer Institute to study the
'"/>

Contact: john_lacey@hms.harvard.edu
public_affairs@hms.harvard.edu
617-432-0442
Harvard Medical School
22-Jun-2005


Page: 1 2 3

Related medicine news :

1. American Cancer Society to hold third annual Virtual Relay For Life in Second Life
2. Cancer research summaries
3. Cancer on the agenda of the Portuguese EU Council Presidency
4. Tony Hunter receives Robert. J. and Claire Pasarow Award for Cancer Research
5. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
6. OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
7. OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival
8. Ireland Cancer Center researcher lays out benefits of aspirin to prevent colon cancer
9. Mayo Clinic Cancer Center researcher finds mold by-product kills multiple myeloma
10. Margaret Foti receives AACR Award for Leadership and Extraordinary Achievements in Cancer Research
11. Cancer-fighting foods, supplements explored in day-long symposium, March 25

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cancer researcher Susan Horwitz wins Alpert prize for Taxol work

(Date:3/29/2015)... Final Cut Pro X ... Film Studios, entitled TranSports. , “TranSports is a ... Cut Pro X,” said Christiana Austin, CEO of Pixel ... to effortlessly transition using this cool sports transition tool.” ... uniquely styled transition pack for Final Cut Pro X. ...
(Date:3/28/2015)... Coffee could not only perk you up in ... disease, researchers have found. , They found that those who ... antioxidants. Antioxidants fight gum disease. Does coffee, then, help fight ... Henry M. Goldman School of Dental Medicine explored in a ... the Journal of Periodontology. , “This is the first long-term ...
(Date:3/28/2015)... March 28, 2015 With more ... the fields of osteoporosis, osteoarthritis and musculoskeletal diseases ... it may be the first time in the ... forum that the hot-button topic is an emerging ... the well-accepted scientific principles of Wolff’s law, osteogenic ...
(Date:3/28/2015)... India Network visitor health insurance announced ... visitors who purchase the plan before arrival in the ... purchase the insurance program as soon as travel plans ... pre-existing medical conditions. Parents and grandparents traveling from India ... serious consequences to their health. Many visitors may not ...
(Date:3/28/2015)... 28, 2015 One in three young ... research presented today at the American Orthopaedic Society for ... examined the long term success of surgery for patients ... survey data from 242 patients who underwent ACL reconstruction ... Roe, MBBS, FRACS, from North Sydney Orthopaedic and Sports ...
Breaking Medicine News(10 mins):Health News:Introducing TranSports for Final Cut Pro X Users from Pixel Film Studios 2Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2
(Date:3/27/2015)... BioCorRx, Inc. ( BICX ... is a healthcare solutions organization, which focuses solely on ... billion in the U.S. alone. The Company created a unique ... a specially compounded form for outpatient surgical implantation. The Company ... New Zealand ) to the specially formulated ...
(Date:3/27/2015)... March 27, 2015  The quality function within the ... products meet quality standards at every stage of the ... quality leaders also have the challenge of balancing quality ... Those who don,t effectively balance these priorities risk funding ... marketplace failure and regulatory scrutiny. For the ...
(Date:3/27/2015)... 27, 2015 Levi & Korsinsky announces it ... OHRP ) concerning possible violations of federal securities ... Company in connection with its study of the drug ... or contact Joseph E. Levi, Esq. ... telephone at (212) 363-7500, toll-free: (877) 363-5972. ...
Breaking Medicine Technology:Small Cap IR Correction -- BioCorRx Inc. Positions Itself Through Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S. 2New Medical Device Quality Study Finds Regulatory Environment is Boosting Quality Spending, Especially for Large Companies 2
Cached News: